Tardive Dyskinesia Awareness Week.
Fiscal committee
No
Current location
Chaptered
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed Assembly
- To Governor
- Became Law
Overview
This resolution declares the week of May 5, 2025, as Tardive Dyskinesia Awareness Week in California. It highlights the importance of recognizing and addressing tardive dyskinesia (TD), a movement disorder linked to long-term antipsychotic medication use. The resolution encourages screening, education, and awareness about TD among healthcare providers, patients, and caregivers to improve patient outcomes and quality of life.
Key provisions
- Declares the week of May 5, 2025, as Tardive Dyskinesia Awareness Week.
- Recognizes the link between antipsychotic medications and tardive dyskinesia.
- Encourages routine TD screening for individuals on antipsychotics.
- Promotes awareness of TD symptoms and risk factors.
- Supports efforts to raise awareness among healthcare providers and patients.
- Highlights the importance of early detection and intervention.
- References the American Psychiatric Association's recommendation for TD screening.
- Acknowledges the availability of FDA-approved treatments for TD.
Who is affected
- Individuals with mental health conditions treated with antipsychotics
- Healthcare providers
- Caregivers of individuals with mental health conditions
- People at risk of tardive dyskinesia (older adults, Black individuals, women, etc.)
- Individuals living with tardive dyskinesia
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
4 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours